Literature DB >> 17298628

Psoas abscess - not as rare as we think?

J P Garner1, P D Meiring, K Ravi, R Gupta.   

Abstract

OBJECTIVE: Iliopsoas abscess (IPA) is a rare condition with a reported worldwide incidence of 12 new cases per year with primary abscesses now predominating. The presentation is often vague and the diagnosis not considered.
METHOD: The medical records of 15 consecutive patients presenting to our hospital in a 3-year period with IPA were reviewed. Demographic data, presenting features, predisposing factors and the investigations performed were recorded. Abscesses were classified as primary or secondary and the treatment provided and eventual outcomes were analysed.
RESULTS: Fifteen patients (eight males) were included. Nine patients were pyrexial on admission, 14 were anaemic and all had raised inflammatory markers. Only five patients presented with the classical triad of pain, fever and limp. The median time to diagnosis was 3 days with a median hospital stay of 27 days (range 7-243 days). Fourteen patients were diagnosed by computed tomographic scan. Three patients were treated with antibiotics alone whilst 11 received percutaneous drainage (PCD) as well. Of these, five had recurrence following initial drainage, needing further PCD procedures but none needed open drainage. Only one patient underwent open drainage initially. The mortality rate was 20%.
CONCLUSION: The incidence of IPA is probably under-reported. The vague presentation leads to delays in diagnosis and increases morbidity and a high index of suspicion is the key to early diagnosis. Percutaneous drainage with antibiotics is the first line of treatment although recurrence rate is high. Open drainage allows simultaneous treatment of underlying pathology in secondary abscesses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17298628     DOI: 10.1111/j.1463-1318.2006.01135.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  24 in total

1.  A Late-onset Psoas Abscess Formation Associated with Previous Appendectomy: A Case Report.

Authors:  Sam Moslemi; Maryam Tahamtan; Seyed Vahid Hosseini
Journal:  Bull Emerg Trauma       Date:  2014-01

2.  Psoas abscess caused by actinomycete together with Escherichia coli infection: a case report and literature review.

Authors:  Qian Chen; Wenyuan Ding; Dalong Yang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 3.  Bacterial, fungal, parasitic, and viral myositis.

Authors:  Nancy F Crum-Cianflone
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

4.  Percutaneous drainage of psoas abscess under real-time computed tomography fluoroscopic guidance.

Authors:  Takuji Yamagami; Koshi Terayama; Rika Yoshimatsu; Tomohiro Matsumoto; Hiroshi Miura; Tsunehiko Nishimura
Journal:  Skeletal Radiol       Date:  2008-11-12       Impact factor: 2.199

5.  Panspinal epidural and psoas abscess with secondary cervical disc space infection.

Authors:  Alireza Shoakazemi; Amit Amit; Nashid Nooralam; Ashraf Abouharb; Mark Gormley; Steven McKinstry
Journal:  Ulster Med J       Date:  2013-01

6.  Neonatal ilio-psoas abscess: report of two cases.

Authors:  Minakshi Sham; Dasmit Singh
Journal:  J Neonatal Surg       Date:  2014-01-01

7.  An easily overlooked presentation of malignant psoas abscess: hip pain.

Authors:  Ayhan Askin; Korhan Baris Bayram; Umit Secil Demirdal; Merve Bergin Korkmaz; Alev Demirbilek Gurgan; Mehmet Fatih Inci
Journal:  Case Rep Orthop       Date:  2015-01-22

8.  A case of primary psoas abscess presenting as buttock abscess.

Authors:  Jae Ho Yoo; Eung Ha Kim; Hyun Seok Song; Jang Gyu Cha
Journal:  J Orthop Traumatol       Date:  2009-11-20

9.  Metallosis, psoas abscess and infected hip prosthesis in a patient with bilateral metal on metal total hip replacement.

Authors:  S Rymaruk; A Razak; R McGivney
Journal:  J Surg Case Rep       Date:  2012-05-01

10.  Primary psoas abscess due to Streptococcus milleri.

Authors:  Nitin B Bagul; Abeywardana M S Abeysekara; Sabu Jacob
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-02-26       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.